mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Keywords

Monoclonal antibodyVirologyAntibodyEpitopeNeutralizationVesicular stomatitis virusMonoclonalBiologyImmunogenicityImmunologyVirus

MeSH Terms

2019-nCoV Vaccine mRNA-1273AdultAgedAntibodiesMonoclonalAntibodiesNeutralizingAntibodiesViralB-LymphocytesBNT162 VaccineCOVID-19COVID-19 VaccinesCryoelectron MicroscopyEpitopesB-LymphocyteFemaleHumansImmunizationSecondaryImmunoglobulin GImmunoglobulin MImmunologic MemoryMaleMiddle AgedModelsMolecularMutationNeutralization TestsSARS-CoV-2Spike GlycoproteinCoronavirusVaccinesSyntheticmRNA Vaccines

Affiliated Institutions

Related Publications

Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine Design

Yuxian He , Jingjing Li , Susanne Heck +2 more

ABSTRACT The spike (S) glycoprotein of severe acute respiratory syndrome coronavirus (SARS-CoV) mediates the receptor interaction and immune recognition and is considered a majo...

2006 Journal of Virology 135 citations

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

Jesper Pallesen , Nianshuang Wang , Kizzmekia S. Corbett +15 more

Significance Coronaviruses such as Middle East respiratory syndrome coronavirus (MERS-CoV) cause severe respiratory distress with high fatality rates. The spike (S) glycoprotein...

2017 Proceedings of the National Academy o... 1186 citations

NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge

Mimi Guebre‐Xabier , Nita Patel , Jing-Hui Tian +10 more

There is an urgent need for a safe and protective vaccine to control the global spread of SARS-CoV-2 and prevent COVID-19. Here, we report the immunogenicity and protective effi...

2020 Vaccine 238 citations

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech , Gary Albert , Iksung Cho +26 more

At 35 days, NVX-CoV2373 appeared to be safe, and it elicited immune responses that exceeded levels in Covid-19 convalescent serum. The Matrix-M1 adjuvant induced CD4+ T-cell res...

2020 New England Journal of Medicine 1219 citations

Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

Xiuyuan Ou , Yan Liu , Xiaobo Lei +15 more

Abstract Since 2002, beta coronaviruses (CoV) have caused three zoonotic outbreaks, SARS-CoV in 2002–2003, MERS-CoV in 2012, and the newly emerged SARS-CoV-2 in late 2019. Howev...

2020 Nature Communications 3353 citations

Publication Info

Year: 2021
Type: article
Volume: 592
Issue: 7855
Pages: 616-622
Citations: 1485
Access: Closed

External Links

Download PDF (Free) View on DOI.org PubMed Semantic Scholar

Social Impact

Altmetric

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1485

OpenAlex

Influential

Cite This

APA Style

                            
                                
                                    Zijun Wang, 
                                
                                    Fabian Schmidt, 
                                
                                    Yiska Weisblum
                                
                                et al.
                            
                            (2021). 
                            mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. 
                            Nature
                            , 592
                            (7855)
                            , 616-622.
                            https://doi.org/10.1038/s41586-021-03324-6
                        

Identifiers

DOI: 10.1038/s41586-021-03324-6
PMID: 33567448
PMCID: PMC8503938

Data Quality

Data completeness: 72%